Founders seeking exit value Sequent Scientific at Rs 2,500 crore

Sequent ’s market cap as on Tuesday was Rs 1,670 crore. But the founders are seeking a control premium of 49.7% or 18-20x forward Ebitda multiple, valuing the company at Rs 2,100-2,500 crore, sources said. Some, however, worry that such expectations may turn out to be a potential deal breaker.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news